Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A288904
Mon, 09.12.2024
SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH)
EQS-WpÜG: SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH) / Tender Offer
Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH)
09.12.2024 / 09:08 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), trans [ … ]
Mon, 09.12.2024
CompuGroup Medical SE & Co. KGaA
Today, CompuGroup Medical SE & Co. KGaA (CGM or the Company), together with its general partner, CompuGroup Medical Management SE, its majority shareholder GT 1 Vermögensverwaltung GmbH (the Majority Shareholder), Kronen 2944 GmbH (to be renamed GT2 Beteiligungen und Software GmbH, GT2) as well as SCUR-Alpha 269 GmbH (to be renamed Caesar BidCo [ … ]
Mon, 09.12.2024
CompuGroup Medical SE & Co. KGaA
Today, CompuGroup Medical SE & Co. KGaA (CGM or the Company), together with its general partner, CompuGroup Medical Management SE, its majority shareholder GT 1 Vermögensverwaltung GmbH (the Majority Shareholder), Kronen 2944 GmbH (to be renamed GT2 Beteiligungen und Software GmbH, GT2) as well as SCUR-Alpha 269 GmbH (to be renamed Caesar BidCo [ … ]
Sun, 08.12.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the share [ … ]
Wed, 31.07.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to [ … ]
Tue, 09.07.2024
CompuGroup Medical SE & Co. KGaA
At CompuGroup Medical SE & Co. KGaA (“CGM”), the preliminary consolidation of revenues for the second quarter and an updated full year forecast result in lower expected revenues than originally anticipated for the financial year 2024.
The reason for the revenue deviation lies in significantly lower non-recurring revenues, particularly in the A [ … ]
Tue, 25.06.2024
CompuGroup Medical SE & Co. KGaA
Today, Profdoc AS, a 100% subsidiary of CompuGroup Medical SE & Co. KGaA, has entered into an agreement with the shareholders of Pridok AS to acquire 100% of the shares in Pridok AS.
Pridok AS with its corporate seat in Tønsberg, Norway, offers a web-based digital patient journal system for the healthcare sector. In the financial year 2023, it [ … ]
Mon, 25.03.2024
CompuGroup Medical SE & Co. KGaA
The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890), utilizing the authorization granted by its annual general meeting of May 19, 2021 pursuant to section 71(1) no. 8 of the German Stock Corporation Act (Aktiengesetz), resolved today to buy back a maximum number of up to 500,000 shares of t [ … ]
Tue, 20.02.2024
CompuGroup Medical SE & Co. KGaA
General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase
Against the background of the stable financial and earnings position the general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend payment to a higher level. Therefore, the general partner plans to propose to the Annual [ … ]